Amazon Biotech Announces Appointment Of Avraham Harris As Director Of Regulatory And Clinical Operations

NEW YORK, NY -- (MARKET WIRE) -- 11/16/2005 -- Amazon Biotech, Inc. (OTC BB: AMZB) announced today the appointment of Avraham Harris as the company’s Director of Regulatory and Clinical Operations. Mr. Harris has been in the pharmaceutical field for over 7 years, working in clinical development, consulting, and clinical monitoring roles for pharmaceutical, biotech and clinical research organization (CRO) companies. Mr. Harris has worked for Perio Products, PAREXEL (Lansal) International and R.A.M. Biotechnology Researches, Ltd. Mr. Harris will oversee the company’s drug development program, taking responsibility for protocol development, IND submissions, regulatory contacts, and other related duties. “I am extremely pleased that Mr. Harris has agreed to be our company’s Director of Regulatory and Clinical Operations,” said Dr. Kanovsky, President of Amazon Biotech. “Mr. Harris has a strong life science background and is very well versed in dealing with regulatory bodies such as the FDA and its European counterparts. We believe that Mr. Harris will add to our capability to successfully complete our current clinical development plan.”

MORE ON THIS TOPIC